# TNGX (Tango Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Tango Therapeutics, Inc. reported $0 in revenue and a net loss of $208.0M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/TNGX
- Markdown: https://convexityos.com/fundamentals/TNGX.md
- SEC CIK: 0001819133
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001819133&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -100.0% YoY |
| Operating Income | TTM | -$228.5M | Operating profit |
| Net Income | TTM | -$208.0M | GAAP bottom line |
| Diluted EPS | TTM | -$1.20 | Split-adjusted |
| Free Cash Flow | TTM | -$150.4M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $977.5M | Total debt: $31.18M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $62.38M | $42.07M | $36.53M | $24.86M | $37.04M | $7.66M |
| Research & Development | $132.2M | $143.9M | $115.2M | $105.9M | $77.64M | $49.99M |
| Total Operating Expenses | $173.7M | $187.7M | $150.7M | $135.9M | $95.23M | $59.86M |
| **Operating Income** | -$111.3M | -$145.6M | -$114.2M | -$111.1M | -$58.19M | -$52.20M |
| **EBITDA** | -$109.0M | -$143.1M | -$111.8M | -$109.5M | -$57.29M | -$51.48M |
| Income Before Tax | -$101.6M | -$130.1M | -$101.6M | -$108.1M | -$57.94M | -$51.97M |
| Income Tax Expense | $4.0K | $208K | $134K | $54K | $292K | $0 |
| **Net Income** | -$101.6M | -$130.3M | -$101.7M | -$108.2M | -$58.23M | -$51.97M |
| Basic EPS | -$0.87 | -$1.19 | -$1.08 | -$1.23 | -$0.94 | -$1.63 |
| **Diluted EPS** | -$0.87 | -$1.19 | -$1.08 | -$1.23 | -$0.94 | -$1.63 |
| Basic Shares Outstanding | 116.2M | 109.2M | 94.6M | 87.8M | 62.1M | 31.9M |
| Diluted Shares Outstanding | 116.2M | 109.2M | 94.6M | 87.8M | 62.1M | 31.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $53.81M | $3.18M | $5.39M | $4.12M |
| Research & Development | $48.93M | $37.20M | $33.53M | $32.10M | $30.82M | $32.81M | $36.44M | $33.94M |
| Total Operating Expenses | $78.12M | $59.78M | $48.77M | $41.86M | $39.74M | $44.15M | $47.92M | $45.03M |
| **Operating Income** | -$78.12M | -$59.78M | -$48.77M | -$41.86M | $14.07M | -$40.97M | -$42.53M | -$40.91M |
| **EBITDA** | -$77.70M | -$59.36M | -$48.31M | -$41.38M | $14.63M | -$40.34M | -$41.91M | -$40.29M |
| Income Before Tax | -$68.39M | -$55.34M | -$45.51M | -$38.80M | $15.87M | -$38.82M | -$39.84M | -$37.62M |
| Income Tax Expense | $0 | $1.0K | $1.0K | -$55K | -$10K | $35K | $34K | $49K |
| **Net Income** | -$68.39M | -$55.34M | -$45.51M | -$38.75M | $15.88M | -$38.85M | -$39.88M | -$37.67M |
| Basic EPS | -$0.39 | -$0.37 | -$0.32 | -- | $0.14 | -$0.35 | -$0.36 | -- |
| **Diluted EPS** | -$0.39 | -$0.37 | -$0.32 | -- | $0.13 | -$0.35 | -$0.36 | -- |
| Basic Shares Outstanding | 173.9M | 149.9M | 143.6M | -- | 111.0M | 110.5M | 110.3M | -- |
| Diluted Shares Outstanding | 173.9M | 149.9M | 143.6M | -- | 117.8M | 110.5M | 110.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $112.3M | $69.53M | $66.39M | $59.97M | $142.7M | $28.38M |
| Short-Term Investments | $230.9M | $188.4M | $270.5M | $306.2M | $342.5M | $161.9M |
| **Cash & Short-Term Investments** | $343.1M | $257.9M | $336.9M | $366.1M | $485.3M | $190.3M |
| Accounts Receivable, Net | -- | -- | -- | $2.00M | $2.00M | $2.00M |
| **Total Current Assets** | $353.8M | $266.3M | $346.5M | $375.3M | $492.3M | $193.6M |
| Property, Plant & Equipment, Net | $6.87M | $8.10M | $9.91M | $10.88M | $4.83M | $3.82M |
| Other Non-Current Assets | $303K | $4.0K | $46K | $5.0K | $19K | $38K |
| **Total Non-Current Assets** | $44.93M | $50.15M | $56.03M | $61.20M | $7.82M | $13.62M |
| **Total Assets** | $398.7M | $316.5M | $402.6M | $436.5M | $500.2M | $207.3M |
| Accounts Payable | $1.18M | $1.60M | $2.79M | $4.45M | $3.23M | $1.84M |
| Deferred Revenue (Current) | $0 | $17.62M | $25.67M | $31.79M | $26.02M | $31.98M |
| **Total Current Liabilities** | $21.68M | $38.17M | $45.94M | $55.55M | $40.69M | $40.92M |
| Deferred Revenue (Non-Current) | $0 | $44.77M | $66.68M | $92.09M | $114.7M | $120.8M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $5.0K |
| **Total Non-Current Liabilities** | $30.83M | $78.81M | $103.5M | $131.4M | $114.7M | $127.7M |
| **Total Liabilities** | $52.51M | $117.0M | $149.5M | $187.0M | $155.4M | $168.7M |
| **Total Debt (incl. Leases)** | $33.57M | $36.49M | $36.49M | $41.13M | $1.50M | $7.88M |
| Common Stock | $136K | $108K | $102K | $88K | $88K | $40K |
| Retained Earnings | -$603.2M | -$501.6M | -$371.3M | -$269.5M | -$161.3M | -$103.1M |
| Accumulated Other Comp. Income | $224K | $336K | $186K | -$3.71M | -$765K | $17K |
| **Total Stockholders' Equity** | $346.2M | $199.5M | $253.1M | $249.5M | $344.7M | $38.60M |
| Total Equity | $346.2M | $199.5M | $253.1M | $249.5M | $344.7M | $38.60M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $86.83M | $345.6M | $157.8M | $112.3M | $58.34M | $58.34M | $58.43M | $69.53M |
| Short-Term Investments | $890.7M | $668.4M | $222.0M | $230.9M | $94.47M | $141.5M | $158.3M | $188.4M |
| **Cash & Short-Term Investments** | $977.5M | $1.00B | $379.8M | $343.1M | $152.8M | $180.8M | $216.7M | $257.9M |
| **Total Current Assets** | $992.7M | $1.03B | $392.3M | $353.8M | $163.8M | $190.1M | $224.9M | $266.3M |
| Property, Plant & Equipment, Net | $5.75M | $6.09M | $6.38M | $6.87M | $7.35M | $7.79M | $7.54M | $8.10M |
| Other Non-Current Assets | $246K | $312K | $293K | $303K | $290K | $310K | $1.0K | $4.0K |
| **Total Non-Current Assets** | $40.80M | $42.21M | $43.47M | $44.93M | $46.36M | $47.79M | $49.38M | $50.15M |
| **Total Assets** | $1.03B | $1.07B | $435.8M | $398.7M | $210.1M | $237.9M | $274.3M | $316.5M |
| Accounts Payable | $1.65M | $1.81M | $2.43M | $1.18M | $2.23M | $2.61M | $3.24M | $1.60M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $0 | $23.37M | $19.48M | $17.62M |
| **Total Current Liabilities** | $25.16M | $20.30M | $14.33M | $21.68M | $18.44M | $40.02M | $35.92M | $38.17M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $0 | $30.44M | $37.51M | $44.77M |
| **Total Non-Current Liabilities** | $28.12M | $29.05M | $29.96M | $30.83M | $31.66M | $62.91M | $71.63M | $78.81M |
| **Total Liabilities** | $53.29M | $49.35M | $44.29M | $52.51M | $50.10M | $102.9M | $107.5M | $117.0M |
| **Total Debt (incl. Leases)** | $31.18M | $31.99M | $32.79M | $33.57M | $34.76M | $35.01M | $36.95M | $36.49M |
| Common Stock | $169K | $168K | $144K | $136K | $112K | $111K | $108K | $108K |
| Retained Earnings | -$772.4M | -$704.0M | -$648.7M | -$603.2M | -$564.4M | -$580.3M | -$541.4M | -$501.6M |
| Accumulated Other Comp. Income | -$4.51M | -$633K | -$115K | $224K | $121K | $94K | $194K | $336K |
| **Total Stockholders' Equity** | $980.2M | $1.02B | $391.5M | $346.2M | $160.0M | $135.0M | $166.8M | $199.5M |
| Total Equity | $980.2M | $1.02B | $391.5M | $346.2M | $160.0M | $135.0M | $166.8M | $199.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$101.6M | -$130.3M | -$101.7M | -$108.2M | -$58.23M | -$51.97M |
| Depreciation & Amortization | $2.28M | $2.50M | $2.42M | $1.61M | $897K | $718K |
| Stock-Based Compensation | $26.43M | $28.90M | $19.08M | $14.23M | $7.83M | $1.76M |
| Change in Receivables | -- | -- | $2.00M | -- | -- | -$2.00M |
| Change in Payables | -$825K | -$1.18M | -$1.71M | $1.10M | $1.23M | $1.17M |
| **Operating Cash Flow** | -$138.9M | -$131.5M | -$118.0M | -$109.1M | -$59.53M | $70.07M |
| Capital Expenditure | -$1.05M | -$754K | -$1.53M | -$7.69M | -$1.84M | -$1.11M |
| **Free Cash Flow** | -$139.9M | -$132.3M | -$119.5M | -$116.8M | -$61.36M | $68.97M |
| Purchases of Investments | -$264.5M | -$240.9M | -$310.6M | -$208.5M | -$372.4M | -$207.5M |
| **Investing Cash Flow** | -$40.87M | $86.13M | $41.43M | $26.40M | -$183.4M | -$145.5M |
| **Financing Cash Flow** | $222.5M | $47.66M | $82.41M | $1.61M | $357.3M | $80.88M |
| **Net Change in Cash** | $42.75M | $2.29M | $5.85M | -$81.07M | $114.4M | $5.49M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$68.39M | -$55.34M | -$45.51M | -$38.75M | $15.88M | -$38.85M | -$39.88M | -$37.67M |
| Depreciation & Amortization | $420K | $425K | $463K | $479K | $555K | $625K | $622K | $620K |
| Stock-Based Compensation | $24.91M | $16.89M | $10.80M | $5.98M | $6.62M | $6.57M | $7.25M | $7.46M |
| Change in Payables | -$160K | -$759K | $1.78M | -$1.23M | -$344K | -$880K | $1.63M | -$2.51M |
| **Operating Cash Flow** | -$37.14M | -$38.87M | -$44.36M | -$29.72M | -$30.95M | -$36.52M | -$41.70M | -$36.65M |
| Capital Expenditure | -$77K | $20K | $2.0K | -$222K | -$151K | -$624K | -$51K | -$124K |
| **Free Cash Flow** | -$37.22M | -$38.85M | -$44.36M | -$29.94M | -$31.10M | -$37.14M | -$41.75M | -$36.77M |
| Purchases of Investments | -$301.5M | -$519.1M | -$54.41M | -$175.0M | -$18.34M | -$23.94M | -$47.16M | -$32.55M |
| **Investing Cash Flow** | -$224.0M | -$446.0M | $9.63M | -$135.7M | $47.48M | $16.78M | $30.60M | $52.06M |
| **Financing Cash Flow** | $2.40M | $672.6M | $79.85M | $219.4M | $2.54M | $581K | $2.0K | $969K |
| **Net Change in Cash** | -$258.7M | $187.7M | $45.12M | $53.94M | $19.07M | -$19.16M | -$11.10M | $16.38M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% | -681.8% |
| **Net Profit Margin** | -162.9% | -309.7% | -278.5% | -435.1% | -157.2% | -678.8% |
| Return on Equity (ROE) | -29.3% | -65.3% | -40.2% | -43.4% | -16.9% | -134.6% |
| Return on Assets (ROA) | -25.5% | -41.2% | -25.3% | -24.8% | -11.6% | -25.1% |
| Current Ratio | 16.32x | 6.98x | 7.54x | 6.76x | 12.10x | 4.73x |
| Quick Ratio | 15.83x | 6.76x | 7.33x | 6.63x | 11.97x | 4.70x |
| Debt to Equity | 0.10x | 0.18x | 0.14x | 0.16x | 0.00x | 0.20x |
| **Revenue Growth (YoY)** | +48.3% | +15.2% | +46.9% | -32.9% | +383.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -184.9% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -189.0% | -- |
| 5Y Revenue / Share Growth | +124.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -253.4% | -206.2% | -178.4% | -165.9% | -647.3% | -355.9% | -346.1% |
| **Net Profit Margin** | -- | -229.9% | -188.2% | -162.9% | -151.1% | -599.1% | -322.7% | -309.7% |
| Return on Equity (ROE) | -21.2% | -12.1% | -27.4% | -29.3% | -62.8% | -107.9% | -79.3% | -65.3% |
| Return on Assets (ROA) | -20.1% | -11.5% | -24.6% | -25.5% | -47.8% | -61.2% | -48.2% | -41.2% |
| Current Ratio | 39.45x | 50.82x | 27.38x | 16.32x | 8.88x | 4.75x | 6.26x | 6.98x |
| Quick Ratio | 38.85x | 49.26x | 26.50x | 15.83x | 8.28x | 4.52x | 6.03x | 6.76x |
| Debt to Equity | 0.03x | 0.03x | 0.08x | 0.10x | 0.22x | 0.26x | 0.22x | 0.18x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | -100.0% | -100.0% | +363.6% | -84.0% | -16.7% | -24.2% |
| Operating Income Growth (YoY) | -655.1% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -530.6% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -378.6% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
